Photo: Eckehard Schulz / AP
American scientists from the National cancer Institute and the cancer center Moffitt came to the conclusion that low doses of aspirin reduce the risk of ovarian cancer. About it reported in a press release on MedicalXpress.
Experts analyzed data collected in the 13 studies that involved 750 thousand women. Among the volunteers, a survey was conducted to assess the level of use of such aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen. More than 3500 women subsequently developed ovarian cancer.
It turned out that low doses of aspirin reduce the risk of malignant tumors by 10 percent.
The results of another study conducted by experts from the center Moffit and the University of Hawaii at Manoa, showed that intake of aspirin and NSAIDs in women with already diagnosed ovarian disease improves the survival rate by 30 percent.
According to the researchers, further studies are needed to determine the dose that can be recommended for treatment and prevention of cancer.
Video, photo All from Russia.